Literature DB >> 19472618

MOSFET dosimetry with high spatial resolution in intense synchrotron-generated x-ray microbeams.

E A Siegbahn1, E Bräuer-Krisch, A Bravin, H Nettelbeck, M L F Lerch, A B Rosenfeld.   

Abstract

Various dosimeters have been tested for assessing absorbed doses with microscopic spatial resolution in targets irradiated by high-flux, synchrotron-generated, low-energy (approximately 30-300 keV) x-ray microbeams. A MOSFET detector has been used for this study since its radio sensitive element, which is extraordinarily narrow (approximately 1 microm), suits the main applications of interest, microbeam radiation biology and microbeam radiation therapy (MRT). In MRT, micrometer-wide, centimeter-high, and vertically oriented swaths of tissue are irradiated by arrays of rectangular x-ray microbeams produced by a multislit collimator (MSC). We used MOSFETs to measure the dose distribution, produced by arrays of x-ray microbeams shaped by two different MSCs, in a tissue-equivalent phantom. Doses were measured near the center of the arrays and maximum/minimum (peak/valley) dose ratios (PVDRs) were calculated to determine how variations in heights and in widths of the microbeams influenced this for the therapy, potentially important parameter. Monte Carlo (MC) simulations of the absorbed dose distribution in the phantom were also performed. The results show that when the heights of the irradiated swaths were below those applicable to clinical therapy (< 1 mm) the MC simulations produce estimates of PVDRs that are up to a factor of 3 higher than the measured values. For arrays of higher microbeams (i.e., 25 microm x 1 cm instead of 25 x 500 microm2), this difference between measured and simulated PVDRs becomes less than 50%. Closer agreement was observed between the measured and simulated PVDRs for the Tecomet MSC (current collimator design) than for the Archer MSC. Sources of discrepancies between measured and simulated doses are discussed, of which the energy dependent response of the MOSFET was shown to be among the most important.

Mesh:

Year:  2009        PMID: 19472618     DOI: 10.1118/1.3081934

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

Review 1.  Microbeam radiosurgery using synchrotron-generated submillimetric beams: a new tool for the treatment of brain disorders.

Authors:  David J Anschel; Alberto Bravin; Pantaleo Romanelli
Journal:  Neurosurg Rev       Date:  2010-11-19       Impact factor: 3.042

2.  High-precision radiosurgical dose delivery by interlaced microbeam arrays of high-flux low-energy synchrotron X-rays.

Authors:  Raphaël Serduc; Elke Bräuer-Krisch; Erik A Siegbahn; Audrey Bouchet; Benoit Pouyatos; Romain Carron; Nicolas Pannetier; Luc Renaud; Gilles Berruyer; Christian Nemoz; Thierry Brochard; Chantal Rémy; Emmanuel L Barbier; Alberto Bravin; Géraldine Le Duc; Antoine Depaulis; François Estève; Jean A Laissue
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

3.  Evaluating the peak-to-valley dose ratio of synchrotron microbeams using PRESAGE fluorescence.

Authors:  N Annabell; N Yagi; K Umetani; C Wong; M Geso
Journal:  J Synchrotron Radiat       Date:  2012-03-15       Impact factor: 2.616

4.  In situ biological dose mapping estimates the radiation burden delivered to 'spared' tissue between synchrotron X-ray microbeam radiotherapy tracks.

Authors:  Kai Rothkamm; Jeffrey C Crosbie; Frances Daley; Sarah Bourne; Paul R Barber; Borivoj Vojnovic; Leonie Cann; Peter A W Rogers
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

5.  Monte Carlo simulation of a compact microbeam radiotherapy system based on carbon nanotube field emission technology.

Authors:  Eric C Schreiber; Sha X Chang
Journal:  Med Phys       Date:  2012-08       Impact factor: 4.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.